Risk Factors for Delays in Adjuvant Chemotherapy following Immediate Breast Reconstruction

Area of Science:

• Oncology
• Plastic Surgery
• Medical Complications

Background:

• Immediate breast reconstruction is a common procedure following mastectomy.
• Concerns exist regarding potential delays in adjuvant chemotherapy initiation due to postoperative complications.
• Timely chemotherapy is crucial for optimal oncologic outcomes.

Purpose of the Study:

• To investigate the impact of postoperative complications on the timing of adjuvant chemotherapy initiation after immediate breast reconstruction.
• To identify specific patient and procedural factors associated with delayed chemotherapy.

Main Methods:

• Retrospective chart review of patients undergoing immediate breast reconstruction and adjuvant chemotherapy between 2010 and 2015.
• Analysis of patients based on the occurrence of postoperative complications and time to chemotherapy initiation.
• Statistical comparison of patient demographics and outcomes between groups with and without complications.

Main Results:

• Of 244 reconstructions, 13.9% experienced postoperative complications.
• Patients with complications were older and had higher rates of diabetes.
• Complications were associated with a delay in chemotherapy initiation (56 vs. 45 days).
• Older age (>51.7 years), diabetes, and autologous reconstruction were identified as risk factors for delayed chemotherapy, with a 74% chance of delay if at least one factor was present.

Conclusions:

• Postoperative complications following immediate breast reconstruction can significantly delay adjuvant chemotherapy.
• Key risk factors for delayed chemotherapy include advanced age, diabetes, and autologous reconstruction.
• Patients with these risk factors require careful consideration and potentially tailored management to ensure timely cancer treatment.